'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries

Paul D. Dobson, Yogendra Patel, Douglas B. Kell

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Present drug screening libraries are constrained by biophysical properties that predict desirable pharmacokinetics and structural descriptors of 'drug-likeness' or 'lead-likeness'. Recent surveys, however, indicate that to enter cells most drugs require solute carriers that normally transport the naturally occurring intermediary metabolites and many drugs are likely to interact similarly. The existence of increasingly comprehensive summaries of the human metabolome allows the assessment of the concept of 'metabolite-likeness'. We compare the similarity of known drugs and library compounds to naturally occurring metabolites (endogenites) using relevant cheminformatics molecular descriptor spaces in which known drugs are more akin to such endogenites than are most library compounds. © 2008 Elsevier Ltd. All rights reserved.
    Original languageEnglish
    Pages (from-to)31-40
    Number of pages9
    JournalDrug discovery today
    Volume14
    Issue number1-2
    DOIs
    Publication statusPublished - Jan 2009

    Fingerprint

    Dive into the research topics of ''Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries'. Together they form a unique fingerprint.

    Cite this